MyHealthChecked Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for MyHealthChecked.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 22.3% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
MyHealthChecked PLC (LON:MHC) Soars 31% But It's A Story Of Risk Vs Reward
Sep 05Market Still Lacking Some Conviction On MyHealthChecked PLC (LON:MHC)
Jun 11There's Been No Shortage Of Growth Recently For MyHealthChecked's (LON:MHC) Returns On Capital
Dec 29Returns Are Gaining Momentum At MyHealthChecked (LON:MHC)
Sep 20MyHealthChecked (LON:MHC) Could Become A Multi-Bagger
May 12MyHealthChecked (LON:MHC) Is Investing Its Capital With Increasing Efficiency
Jan 06We Think MyHealthChecked's (LON:MHC) Profit Is Only A Baseline For What They Can Achieve
Jun 14In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as MyHealthChecked has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2024 | 9 | -1 | 1 | 1 | N/A |
3/31/2024 | 10 | -1 | 1 | 1 | N/A |
12/31/2023 | 11 | 0 | 0 | 1 | N/A |
9/30/2023 | 13 | 0 | -1 | 0 | N/A |
6/30/2023 | 15 | 0 | -2 | -2 | N/A |
3/31/2023 | 19 | 1 | 0 | 0 | N/A |
12/31/2022 | 22 | 2 | 1 | 2 | N/A |
9/30/2022 | 23 | 2 | 3 | 3 | N/A |
6/30/2022 | 23 | 3 | 5 | 5 | N/A |
3/31/2022 | 20 | 3 | 4 | 4 | N/A |
12/31/2021 | 16 | 2 | 3 | 3 | N/A |
9/30/2021 | 10 | 0 | 0 | 0 | N/A |
6/30/2021 | 3 | -3 | -2 | -2 | N/A |
3/31/2021 | 2 | -3 | -2 | -2 | N/A |
12/31/2020 | 0 | -4 | -2 | -2 | N/A |
9/30/2020 | 0 | -3 | -2 | -2 | N/A |
6/30/2020 | 0 | -2 | -2 | -2 | N/A |
3/31/2020 | 0 | -2 | -2 | -2 | N/A |
12/31/2019 | 0 | -2 | -2 | -2 | N/A |
9/30/2019 | 0 | -2 | -3 | -2 | N/A |
6/30/2019 | 0 | -3 | -3 | -2 | N/A |
3/31/2019 | 0 | -3 | -3 | -2 | N/A |
12/31/2018 | 0 | -3 | -3 | -2 | N/A |
9/30/2018 | 0 | -3 | -3 | -2 | N/A |
6/30/2018 | 0 | -3 | -3 | -3 | N/A |
3/31/2018 | 0 | -3 | N/A | -3 | N/A |
12/31/2017 | 0 | -2 | N/A | -2 | N/A |
6/30/2017 | N/A | -3 | N/A | -2 | N/A |
12/31/2016 | N/A | -3 | N/A | -1 | N/A |
1/31/2016 | 0 | -1 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if MHC's forecast earnings growth is above the savings rate (2.1%).
Earnings vs Market: Insufficient data to determine if MHC's earnings are forecast to grow faster than the UK market
High Growth Earnings: Insufficient data to determine if MHC's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if MHC's revenue is forecast to grow faster than the UK market.
High Growth Revenue: Insufficient data to determine if MHC's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MHC's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 11:36 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
MyHealthChecked PLC is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Huub Verschueren | Life Sciences Research International BV |